首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1937063

全球精準醫療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Precision Medicine Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 227 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計精準醫療市場將從 2025 年的 930.6 億美元成長到 2034 年的 3,861.6 億美元，2026 年至 2034 年的複合年成長率為 17.13%。

基因組學、生物技術和數據分析的進步使得針對每位患者的個人化治療方案成為可能，推動了精準醫療市場的快速成長。隨著醫療保健向個人化護理轉型，對精準醫療解決方案的需求日益成長，尤其是在腫瘤領域，標靶標靶治療正在革新癌症治療。透過整合基因檢測和生物標記識別，醫療服務提供者現在可以製定客製化的治療方案，從而最佳化治療效果並最大限度地減少副作用。隨著患者和醫療服務提供者尋求更有效、更個人化的醫療解決方案，這一趨勢預計將進一步推動市場發展。

技術和數據管理的創新也在塑造精準醫療市場的未來前景。人工智慧 (AI) 和機器學習的興起提高了分析複雜資料集的能力，從而實現了患者分層並改善了治療效果。此外，生物資訊學的進步正在促進基因組數據與醫療實踐的整合，使醫療服務提供者能夠根據患者獨特的基因譜做出明智的決策。隨著這些技術的不斷發展，預計精準醫療的應用將擴展到包括罕見疾病和慢性病在內的各個治療領域。

此外，隨著製藥公司和醫療機構意識到個人化醫療的潛力，加大研發投入將對精準醫療市場產生正面影響。學術機構、產業相關人員和監管機構之間的合作對於推動臨床試驗和成功實施精準醫療策略至關重要。在這種不斷變化的環境下，重點預計將轉向將精準醫療融入標準治療方案，而跨學科方法在實現最佳患者療效方面的重要性也將得到強調。

區域分析
北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家

第13章競爭格局

最新趨勢
公司分類
供應鏈和銷售管道合作夥伴（根據現有資訊）
市場佔有率和市場定位分析（基於現有資訊）
供應商情況（基於現有資訊）
策略規劃

第14章：公司簡介

主要公司的市佔率分析
公司簡介
- Biocrates Life Sciences
- Tepnel Pharma Services
- Novartis
- Qiagen
- Quest Diagnostics
- Menarini Silicon Biosystems
- NanoString Technologies
- Eagle Genomics
- Pfizer
- Intomics
- Roche
- Teva Pharmaceutical

簡介目錄

Product Code: VMR11214898

The Precision Medicine Market size is expected to reach USD 386.16 Billion in 2034 from USD 93.06 Billion (2025) growing at a CAGR of 17.13% during 2026-2034.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

Bioinformatics
Big Data Analytics
Drug Discovery
Gene Sequencing
Companion Diagnostics
Others

By Application

CNS
Immunology
Oncology
Respiratory
Others

By End-Use

Diagnostic Companies
Pharmaceutical Companies
Healthcare IT companies
Others
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Chain Termination Sequencing
Nanopore Sequencing

By Product

Consumables
Instruments
Services

By Route of Administration

Oral
Injectable

By Drugs

Alectinib
Osimertinib
Mepolizumab
Aripiprazole Lauroxil
Others

COMPANIES PROFILED

Biocrates Life Sciences, Tepnel Pharma Services, Novartis, Qiagen, Quest Diagnostics, Menarini Silicon Biosystems, NanoString Technologies, Eagle Genomics, Pfizer, Intomics, Roche, Teva Pharmaceutical

We can customise the report as per your requriements

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Technology
4.2. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Big Data Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Gene Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Companion Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. CNS Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION MEDICINE MARKET: BY END-USE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End-use
6.2. Diagnostic Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Healthcare IT companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION MEDICINE MARKET: BY SEQUENCING BY SYNTHESIS 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Sequencing By Synthesis
7.2. Ion Semiconductor Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRECISION MEDICINE MARKET: BY SEQUENCING BY LIGATION 2022-2034 (USD MN)

8.1. Market Analysis, Insights and Forecast Sequencing By Ligation
8.2. Pyrosequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Single Molecule Real Time Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Chain Termination Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.5. Nanopore Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PRECISION MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

9.1. Market Analysis, Insights and Forecast Product
9.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PRECISION MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

10.1. Market Analysis, Insights and Forecast Route Of Administration
10.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
10.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL PRECISION MEDICINE MARKET: BY DRUGS 2022-2034 (USD MN)

11.1. Market Analysis, Insights and Forecast Drugs
11.2. Alectinib Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.3. Osimertinib Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.4. Mepolizumab Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.5. Aripiprazole Lauroxil Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 12. GLOBAL PRECISION MEDICINE MARKET: BY REGION 2022-2034(USD MN)

12.1. Regional Outlook
12.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.2.1 By Technology
- 12.2.2 By Application
- 12.2.3 By End-use
- 12.2.4 By Sequencing By Synthesis
- 12.2.5 By Sequencing By Ligation
- 12.2.6 By Product
- 12.2.7 By Route Of Administration
- 12.2.8 By Drugs
- 12.2.9 United States
- 12.2.10 Canada
- 12.2.11 Mexico
12.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.3.1 By Technology
- 12.3.2 By Application
- 12.3.3 By End-use
- 12.3.4 By Sequencing By Synthesis
- 12.3.5 By Sequencing By Ligation
- 12.3.6 By Product
- 12.3.7 By Route Of Administration
- 12.3.8 By Drugs
- 12.3.9 United Kingdom
- 12.3.10 France
- 12.3.11 Germany
- 12.3.12 Italy
- 12.3.13 Russia
- 12.3.14 Rest Of Europe
12.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.4.1 By Technology
- 12.4.2 By Application
- 12.4.3 By End-use
- 12.4.4 By Sequencing By Synthesis
- 12.4.5 By Sequencing By Ligation
- 12.4.6 By Product
- 12.4.7 By Route Of Administration
- 12.4.8 By Drugs
- 12.4.9 India
- 12.4.10 Japan
- 12.4.11 South Korea
- 12.4.12 Australia
- 12.4.13 South East Asia
- 12.4.14 Rest Of Asia Pacific
12.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.5.1 By Technology
- 12.5.2 By Application
- 12.5.3 By End-use
- 12.5.4 By Sequencing By Synthesis
- 12.5.5 By Sequencing By Ligation
- 12.5.6 By Product
- 12.5.7 By Route Of Administration
- 12.5.8 By Drugs
- 12.5.9 Brazil
- 12.5.10 Argentina
- 12.5.11 Peru
- 12.5.12 Chile
- 12.5.13 South East Asia
- 12.5.14 Rest of Latin America
12.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.6.1 By Technology
- 12.6.2 By Application
- 12.6.3 By End-use
- 12.6.4 By Sequencing By Synthesis
- 12.6.5 By Sequencing By Ligation
- 12.6.6 By Product
- 12.6.7 By Route Of Administration
- 12.6.8 By Drugs
- 12.6.9 Saudi Arabia
- 12.6.10 UAE
- 12.6.11 Israel
- 12.6.12 South Africa
- 12.6.13 Rest of the Middle East And Africa

Chapter 13. COMPETITIVE LANDSCAPE

13.1. Recent Developments
13.2. Company Categorization
13.3. Supply Chain & Channel Partners (based on availability)
13.4. Market Share & Positioning Analysis (based on availability)
13.5. Vendor Landscape (based on availability)
13.6. Strategy Mapping

Chapter 14. COMPANY PROFILES OF GLOBAL PRECISION MEDICINE INDUSTRY

14.1. Top Companies Market Share Analysis
14.2. Company Profiles
- 14.2.1 Biocrates Life Sciences
- 14.2.2 Tepnel Pharma Services
- 14.2.3 Novartis
- 14.2.4 Qiagen
- 14.2.5 Quest Diagnostics
- 14.2.6 Menarini Silicon Biosystems
- 14.2.7 NanoString Technologies
- 14.2.8 Eagle Genomics
- 14.2.9 Pfizer
- 14.2.10 Intomics
- 14.2.11 Roche
- 14.2.12 Teva Pharmaceutical